Taavi Rand | Medicine and Health Sciences | Innovative Research Award

Innovative Research Award

Taavi Rand
University of Tartu, Estonia

Taavi Rand
Affiliation University of Tartu
Country Estonia
Google Scholar ID 02uTcusAAAAJ
Documents 1
Subject Area Medicine and Health Sciences
Event International Research Hypothesis Excellence Award
ORCID 0009-0000-9511-6302

Taavi Rand the Innovative Research Award article summarizes the academic profile of Taavi Rand, a researcher affiliated with the University of Tartu, Estonia. The page presents an overview of the researcher’s scholarly activity, publication record, institutional affiliation, and relevance to the International Research Hypothesis Excellence Award. The information is organized in an encyclopedic format intended for academic reference and is based on publicly available scholarly sources and publication metadata.[1]

Abstract

Taavi Rand’s current scholarly record reflects research interests in medicine and health sciences with emphasis on evidence-based intervention design for adolescent health behaviour. The available publication demonstrates participation in collaborative research focused on study methodology and protocol development, providing an organized framework for evaluating health interventions in educational environments. Such methodological work contributes to reproducibility, transparency, and future clinical implementation within public health research.[2]

Keywords

Medicine, Health Sciences, Intervention Research, Study Protocol, Adolescent Health, Behaviour Change, University of Tartu, Scientific Publication.

Introduction

Academic recognition frequently considers publication quality, institutional affiliation, methodological rigor, and the broader significance of ongoing research. Study protocols are an important component of scientific communication because they establish predefined objectives, research methods, and evaluation procedures before primary findings become available. This practice supports research integrity and facilitates independent assessment by the scientific community.[3]

Research Profile

Taavi Rand is affiliated with the University of Tartu in Estonia. The currently available publication profile indicates participation in multidisciplinary research concerning health behaviour change among students. The research aligns with contemporary priorities in preventive medicine and public health by emphasizing structured intervention planning and standardized evaluation methodologies.[1]

Research Contributions

The principal documented contribution involves the development of the FiTeens intervention study protocol. Protocol publications improve research quality by describing participant selection, outcome measures, ethical considerations, and statistical approaches before data analysis begins. This strengthens reproducibility while enabling future investigators to compare methodologies across related studies.[4]

Publications

Evaluating Effectiveness of the FiTeens Intervention for Health Behavior Change in Students: A Study Protocol. Methods and Protocols, July 2026.

Research Impact

Although citation metrics are presently unavailable in the supplied profile, protocol publications often establish the methodological basis for future clinical and educational investigations. Their influence is commonly reflected through subsequent implementation studies, systematic reviews, and collaborative research initiatives that build upon the original study design.[5]

Award Suitability

Based on the available scholarly information, the documented work demonstrates characteristics commonly associated with academic recognition, including methodological transparency, interdisciplinary collaboration, and contributions to preventive health research. Evaluation for the International Research Hypothesis Excellence Award would appropriately consider originality, scientific rigor, ethical standards, publication quality, and future research potential alongside conventional bibliometric indicators.[6]

Conclusion

The presently available academic record highlights Taavi Rand’s participation in contemporary health sciences research through a peer-reviewed study protocol addressing student health behaviour interventions. While the publication portfolio currently consists of a single documented work, it reflects adherence to accepted scientific reporting standards and provides a foundation for future scholarly development and measurable research impact.

References

  1. Google Scholar. (n.d.). Author profile: Taavi Rand.
    https://scholar.google.com/citations?hl=en&user=02uTcusAAAAJ
  2. MDPI. (2026). Evaluating Effectiveness of the FiTeens Intervention for Health Behavior Change in Students: A Study Protocol.
    https://www.mdpi.com/2409-9279/9/4/101
  3. DOI Foundation. DOI: 10.3390/mps9040101.
  4. University of Tartu. Institutional information.
  5. ORCID. Researcher identifier: 0009-0000-9511-6302.
    https://orcid.org/0009-0000-9511-6302
  6. International Research Hypothesis Excellence Award. Award information.
    researchhypothesis.com

Emmanouil Dermitzakis | Medicine and Health Sciences | Best Researcher Award

Emmanouil Dermitzakis | Medicine and Health Sciences | Best Researcher Award

Dr Emmanouil Dermitzakis, Euromedica General Clinic, Greece

Dr. Emmanouil Dermitzakis appears to be a strong candidate for the Best Researcher Award based on the following criteria:

Publication profile

google scholar

Qualifications & Experience

Extensive Training and Certification: Dr. Dermitzakis has undergone comprehensive training in Internal Medicine, Psychiatry, and Neurology, with board certification in Neurology.

Diverse Clinical Experience: He has worked in various roles, including as a research fellow, neurologist in multiple settings, and medical advisor. His roles have spanned private practice, academic institutions, and specialized clinics.

Research Contributions

Clinical Trials & Studies: Dr. Dermitzakis has been involved as both a Sub-Investigator and Principal Investigator in numerous significant clinical trials, such as the ECASS 3 trial and various migraine-related studies. His research includes evaluating new treatments and methodologies for migraine and headache disorders.

Published Works: He has published numerous articles in reputable journals, covering a wide range of topics from headache management to the effects of chemotherapy on the autonomic nervous system. His work includes research on migraine treatments, including botulinum toxin and novel therapies.

Editorial and Advisory Roles

Guest Editor: He has served as a Guest Editor for a special issue on headache disorders, reflecting his expertise and leadership in the field.

Medical Advisory Roles: As a medical advisor for the Hellenic Society of Migraine and Headache Patients, Dr. Dermitzakis contributes to advancing treatment strategies and improving patient care.

Notable Publications

His research includes impactful studies such as the evaluation of onabotulinumtoxinA in chronic migraine treatment, and the effects of chemotherapy on the autonomic nervous system. These contributions have been published in high-impact journals like The Journal of Headache and Pain and BMC Neurology.

Conclusion

Dr. Dermitzakis’s combination of clinical expertise, substantial research experience, leadership in neurology and headache management, and influential publications make him a notable candidate for the Best Researcher Award. His ongoing contributions to neurology and headache research demonstrate a commitment to advancing medical knowledge and improving patient outcomes.

Publication top notes

Patients’ preferences for headache acute and preventive treatment

Clinical experience with transcutaneous supraorbital nerve stimulation in patients with refractory migraine or with migraine and intolerance to topiramate: a prospective …

Sustained onabotulinumtoxinA therapeutic benefits in patients with chronic migraine over 3 years of treatment

Onabotulinumtoxin-A treatment in Greek patients with chronic migraine

The impact of paclitaxel and carboplatin chemotherapy on the autonomous nervous system of patients with ovarian cancer

Headache patients in the emergency department of a Greek tertiary care hospital

OnabotulinumtoxinA add-on to monoclonal anti-CGRP antibodies in treatment-refractory chronic migraine

Open label prospective experience of supplementation with a fixed combination of magnesium, vitamin B2, feverfew, andrographis paniculata and coenzyme Q10 for episodic migraine …

Long‐term adherence, safety, and efficacy of repeated onabotulinumtoxinA over five years in chronic migraine prophylaxis

Efficacy and safety of fremanezumab for migraine prophylaxis in patients with at least three previous preventive failures: prospective, multicenter, real‐world data from a …